Mariscos Procesados (CAMPRESA), a seafood processor from Nicaragua, has been issued a warning letter by the US Food and Drug Administration (FDA) for adulterated mahi-mahi fillets.
The warning letter, dated Nov. 5, 2024, was published by the FDA on Tuesday (March 4). Per the notice, the FDA inspected the Mariscos Procesados facility in August 2024 and found "serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation."
While the company issued the FDA a revised HACCP plan, the US agency said the plan was inadequate.
"Accordingly, your frozen mahi-mahi fillets in vacuum-packaging products, are adulterated, in that they have been prepared, packed, or held under conditions whereby they may have been rendered injurious to health," the FDA noted in the warning letter.
Specifically, the FDA flagged CAMPRESA for failure to control histamines during transit to its facility, and also failure to control the hazard of C. botulinum toxin formation during finishing of frozen mahi-mahi fillets in vacuum-packaging product storage.
Comments (0)
To view or post comments, simply
Already registered? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.